Thermo Fisher Scientific
81 Wyman Street
1357 articles with Thermo Fisher Scientific
New-Generation, High-Precision Isotope Ratio Mass Spectrometry System Delivers Analysis for Geosciences, Nuclear Safeguards and Medical Research Applications
Thermo Scientific Neoma Multicollector ICP-MS extracts reliable isotopic data from even the smallest samples, with new levels of sensitivity, accuracy and productivity
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Evercore ISI HealthCONx Conference on Tuesday, December 1, 2020, at 1:00 p.m. (EST).
As of late, the company has already tested almost 15,000 of its 75,000 employees in a pilot program.
Thermo Fisher Scientific Inc., the world leader in serving science, announced it has elected R. Alexandra "Alex" Keith to its board of directors.
Thermo Scientific Tundra Cryo-TEM Democratizes Cryo-Electron Microscopy, Extends to Users of Any Experience Level
Thermo Fisher Scientific, the world leader in serving science, today announced the new Thermo Scientific Tundra Cryo Transmission Electron Microscope (Cryo-TEM), a groundbreaking instrument that extends cryo-electron microscopy (cryo-EM) to more scientists by delivering industry-leading ease of use at an affordable price.
Leading Diagnostics Companies Join Forces to Establish the Access to Comprehensive Genomic Profiling Coalition (ACGP)
Consortium aims to make comprehensive genomic profiling accessible to advanced cancer patients in the U.S. to inform medical management and improve patient outcomes.
Thermo Scientific Axia ChemiSEM Increases Data Acquisition Speed, Simplicity for Materials Micro-Analysis
Thermo Fisher Scientific today unveiled the Thermo Scientific Axia ChemiSEM, a cost-effective, floor-model scanning electron microscope (SEM) that takes materials micro-structural analysis and defect discovery to a new level of speed and simplicity.
Thermo Fisher Scientific and Innoforce Partner to Establish Biologics and Steriles Drug Manufacturing Facility in China
Thermo Fisher Scientific Inc., the world leader in serving science, and Innoforce, a bioinnovation-enabling company, announced they have signed a joint venture agreement to establish a new pharma services facility in Hangzhou, China, for integrated biologics and steriles drug development and manufacturing.
Thermo Fisher Scientific Declares Quarterly Dividend and Authorizes $2.5 Billion of Share Repurchases - Nov 05, 2020
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its board of directors declared a quarterly cash dividend of $0.22 per share.
Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows
Thermo Fisher and the Biopharmaceutical Analysis Training Laboratory (BATL) of Northeastern University aim to deliver cutting-edge analytical solutions and training programs
Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research
Thermo Fisher Scientific today announced it signed a partnership agreement with the newly formed Terasaki Innovation Center (TIC) to facilitate discovery and development of new pathways and tools to diagnose and better manage transplant patients. The mission of the TIC is to continue the research of Dr. Paul I. Terasaki , t
Thermo Fisher Scientific Extends Collaboration to Advance Biopharmaceutical Discovery and Development
Thermo Fisher and Symphogen continue work to support the development of innovative cancer treatments through optimization of protein characterization and quality monitoring mass spectrometry workflows
Thermo Fisher Scientific Inc.Thermo Fisher Scientific Inc.Thermo Fisher Scientific Inc.Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the third quarter ended September 26, 2020.
Thermo Fisher Scientific Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, announced it has received an expansion of its Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a leading digital health testing company. The TaqPath test is aut
Thermo Fisher Scientific Launches Modular Closed Cell Processing System for Cell Therapy Manufacturing
Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. The CTS Rotea system is the first Gibco instrument for cell therapy processing applications and
Thermo Fisher Scientific Announces Plans to Expand Sterile Filling Capacity for Therapies and Vaccines with New Facility in Singapore
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced plans to develop two new sterile filling lines in Singapore to extend capacity to the Asia-Pacific region for the development a
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020.
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. These new tests for detecting COVID-19 antibodies expand the company's leading
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter of 2020 before the market opens on Wednesday, October 21, 2020 , and will hold a conference call on the same day at 8:30 a.m. EDT . During the call, the company will discuss
Program will leverage Ion Torrent Genexus System* and Oncomine Precision Assay* to advance precision medicine for lung cancer in Asia